Filing Details
- Accession Number:
- 0001655759-23-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-03 21:51:13
- Reporting Period:
- 2023-03-01
- Accepted Time:
- 2023-03-03 21:51:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1655759 | Arvinas Inc. | ARVN | Pharmaceutical Preparations (2834) | 472566120 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1753281 | Ian Taylor | C/O Arvinas, Inc. 5 Science Park, 395 Winchester Ave. New Haven CT 06511 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-03-01 | 2,685 | $0.00 | 102,772 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-03-01 | 1,051 | $29.53 | 101,721 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2023-03-01 | 2,685 | $0.00 | 2,685 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
- This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
- The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at a price of $29.53.
- On March 1, 2019, the reporting person was granted 10,742 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.